P. Sadler
Chemical Communications · 2005–2013
A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from P. Sadler's perspective
Ordered by how strongly the researchers P. Sadler trusts endorse each paper. Same corpus, a different order for every researcher.
- In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes. (Journal of Medicinal Chemistry)
- Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes. (Chemical Communications)
- Direct cellular responses to platinum-induced DNA damage. (Chemical Reviews)
- Nanoscale coordination polymers for platinum-based anticancer drug delivery. (Journal of the American Chemical Society)
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. (Proceedings of the National Academy of Sciences of the United States of America)
- Metal-based antitumour drugs in the post genomic era. (Dalton Transactions)
- Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system (Nature)
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles (Molecular Pharmaceutics)
- Proteomic analysis of the mode of antibacterial action of silver nanoparticles. (Journal of Proteome Research)
- Bactericidal Actions of a Silver Ion Solution on Escherichia coli, Studied by Energy-Filtering Transmission Electron Microscopy and Proteomic Analysis (Applied and Environmental Microbiology)
Their papers
- Exploration of the medical periodic table: towards new targets. (2013) — 651 citations
- Metal complexes as DNA intercalators. (2011) — 679 citations
- ‘New Trends for Metal Complexes with Anticancer Activity’ (2008) — 1,236 citations
- Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes. (2005) — 642 citations